Mineralys Therapeutics, Inc. (MLYS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $172.92M | +51.6% |
| 2024 | $114.09M | +131.4% |
| 2023 | $49.30M | -43.8% |
| 2022 | $87.70M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $172.92M | +51.6% |
| 2024 | $114.09M | +131.4% |
| 2023 | $49.30M | -43.8% |
| 2022 | $87.70M | — |